Singapore legislation
Regulation 38
of Healthcare Services (Assisted Reproduction Service) Regulations 2023
Regulation 38
Restriction on the use of certain embryos
Subregulation 1
A licensee must, before carrying out any procedure that will result in the fertilisation of an intergenerational embryo —
obtain approval for the procedure from a clinical ethics committee appointed by a section 25 licensee; and
obtain signed written consent for the procedure and the intended use of the intergenerational embryo from each person from whom the reproductive cells for the fertilisation of the intergenerational embryo were collected.
Subregulation 2
Except with the Clinical Governance Officer’s written approval, a licensee must not transfer into the body of a patient any embryo that is created from a reproductive cell collected from a donor whose donated reproductive cells had previously resulted in at least 5 live birth events.
Subregulation 3
The Clinical Governance Officer must not approve the transfer of an embryo mentioned in paragraph (2) to a patient unless —
another embryo created from reproductive cells collected from the donor had previously been transferred to the patient, and resulted in a live birth event; and
the patient has requested the transfer.
Subregulation 4
In this regulation, “intergenerational embryo” means an embryo created from —
an oocyte from a woman and sperm collected from the biological father of the woman’s husband; or
sperm collected from a man and an oocyte collected from the biological mother of the man’s wife.